| Literature DB >> 33953561 |
Ulrika Fernberg1, Maria Fernström2, Anita Hurtig-Wennlöf1,3.
Abstract
PURPOSE: Arterial stiffness describes the rigidity of the arterial walls and is associated with risk factors for cardiovascular disease (CVD). Arterial stiffness predicts future events and mortality, and the predictive value is stronger in younger versus older subjects. The aims of the present study were, firstly, to present data on physical activity (PA) and time spent sedentary, in the population of Swedish, young adults. Secondly, to explore the association between PA and arterial stiffness.Entities:
Keywords: accelerometry; atherosclerosis; healthy population; pulse wave analysis; pulse wave velocity
Mesh:
Year: 2021 PMID: 33953561 PMCID: PMC8092620 DOI: 10.2147/VHRM.S283211
Source DB: PubMed Journal: Vasc Health Risk Manag ISSN: 1176-6344
Figure 1Sampling procedure of the physical activity (PA) data in the Lifestyle, Biomarkers, and Atherosclerosis Study.
Basic Characteristics in the Study Participants with Valid Physical Activity (PA) Data
| Women (n=478) | Men (n=180) | ||||
|---|---|---|---|---|---|
| Age (years) | 21.9 | 1.9 | 22.1 | 2.0 | 0.340 |
| Height (cm) | 168.6 | 6.2 | 181.6 | 6.5 | <0.001 |
| Weighta (kg) | 62.3 | (56.1–68.1) | 75.8 | (69.8–83.7) | <0.001 |
| BMIa (kg/m2) | 21.7 | (20.0–23.8) | 22.7 | (21.3–25.2) | <0.001 |
| Body fat (%) | 27.7 | 6.5 | 15.0 | 4.2 | <0.001 |
| Triglyceridesa (mmol/L) | 0.7 | (0.6–1.0) | 0.7 | (0.6–0.9) | 0.406 |
| HDL-C (mmol/L) | 1.4 | 0.4 | 1.2 | 0.3 | <0.001 |
| Glucose (mmol/L) | 4.9 | 0.3 | 5.1 | 0.3 | <0.001 |
| HOMA-IRa | 1.6 | (1.1–2.2) | 1.5 | (1.1–2.0) | 0.444 |
| hs-CRP (mg/L) | 0.7 | (0.3–1.9) | 0.6 | (0.2–1.3) | <0.01 |
| SBP (mmHg) | 110 | 9 | 122 | 11 | <0.001 |
| DBP (mmHg) | 64 | 6 | 64 | 7 | 0.352 |
| MAP (mmHg) | 80 | 7 | 85 | 7 | <0.001 |
| PWV (m/s) | 5.2 | 0.7 | 5.5 | 0.9 | <0.001 |
| AIx_HR75 | −5.0 | 9.7 | −9.3 | 8.7 | <0.001 |
| Sedentarya (min/day) | 523 | (481–565) | 547 | (506–593) | <0.001 |
| LPAa (min/day) | 214 | (187–244) | 202 | (176–231) | <0.01 |
| MPAa (min/day) | 38 | (28–51) | 38 | (27–47) | 0.339 |
| VPAa (min/day) | 3.3 | (0.4–9.4) | 2.9 | (0.6–8.1) | 0.152 |
| MVPAa (min/day) | 45 | (31–58) | 44 | (29–56) | 0.527 |
| Total PAa (min/day) | 263 | (226–298) | 249 | (218–281) | <0.01 |
| Stepsa (steps/day) | 7796 | (6123–9403) | 7336 | (5773–8749) | <0.05 |
Notes: Data are presented in women and men as mean and standard deviation (SD), and as amedian and interquartile range (Q1-Q3). Mean differences between the women and men were analyzed by unpaired Student t-test. Logarithms were made of skewed variables before the analyses. Level of significance was set at P<0.05.
Abbreviations: BMI, body mass index, body fat, percentage of body fat; DBP, brachial diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; hs-CRP, high-sensitive C-reactive protein; LPA, light-intensity physical activity; MAP, brachial mean arterial pressure; MPA, moderate-intensity physical activity; MVPA, moderate and vigorous physical activity; SBP, brachial systolic blood pressure; total PA, total physical activity (LPA+MVPA); VPA, vigorous-intensity physical activity.
Distribution of Time Spent in Different Physical Activity Intensity Levels (Min/Day) and Steps per Day, in the Total Population, Divided in the Categories At Risk and Not At Risk According to Wildman’s Risk Score
| Time Spent in PA Levels per Day | At Risk (n=68) | Not at Risk (n=590) | |
|---|---|---|---|
| Sedentary (min/day) | 538 (481–588) | 528 (484–572) | 0.646 |
| LPA (min/day) | 203 (169–233) | 211 (186–242) | <0.01 |
| MVPA (min/day) | 41 (27–57) | 45 (31–57) | 0.178 |
| Total PA (min/day) | 238 (213–283) | 262 (226–296) | <0.01 |
| Steps (steps/day) | 7254 (5650–8699) | 7625 (6077–9334) | 0.062 |
Notes: Results (median and Q1–Q3) are presented in the total population at risk and not at risk according to Wildman’s risk score. Mean differences in time spent in different intensity levels (min/day) between study participants at risk and not at risk were analyzed with unpaired Student t-test. Level of significance was set at P<0.05.
Abbreviations: LPA, light-intensity physical activity; MVPA, moderate and vigorous physical activity; total PA, total physical activity (LPA+MVPA).
Figure 2AIx_HR75 (Augmentation index adjusted to heart rate 75 beats/min) in the moderate and vigorous physical activity (MVPA) categories not reaching 30 minutes MVPA per day (n=157), reaching 30 minutes MVPA per day (n=353), and reaching 60 minutes MVPA per day (n=144) in total population with valid physical activity data. Study participants who spent <30 minutes per day in MVPA had significantly higher AIx_HR75 than study participants who spent >60 minutes/day in MVPA, *P<0.05.
Simple Linear Regression Coefficients (β) and Standardized β (Stand β) Between Regional Stiffness Measurements as Dependent Variables and Physical Activity Levels as Independent Variables, in Women and Men
| PWV (m/s) | AIx_HR75 | |||||||
|---|---|---|---|---|---|---|---|---|
| Time Spent in PA Levels per Day | Women | Men | Women | Men | ||||
| β | Stand. β | β | Stand. β | β | Stand. β | β | Stand. β | |
| Sedentary (min/day) | 0.001 | 0.086 | 0.000 | 0.006 | 0.012 | 0.089 | 0.001 | 0.007 |
| LPA (min/day) | −0.126 | −0.038 | −0.300 | −0.089 | −2.377 | −0.053 | −4.568 | −0.134 |
| MVPA (min/day) | −0.148 | −0.104 | 0.011 | 0.007 | −3.197** | −0.166** | −0.610 | −0.037 |
| Total PA (min/day) | −0.260 | −0.076 | −0.009 | −0.088 | −5.348 | −0.116 | −5.685 | −0.153 |
| Steps (steps/day) | −0.271 | −0.128 | −0.070 | −0.030 | −4.276* | −0.150* | −2.693 | −0.115 |
Notes: Simple linear regression coefficients (unstandardized β) and standardized β are presented in women (n=478) and men (n=180) separately. Significance levels after Bonferroni correction; *P<0.0025, **P<0.0005.
Abbreviations: AIx_HR75, augmentation index adjusted to heart rate 75 bpm; LPA, light physical activity; MVPA, moderate and vigorous physical activity; PWV (m/s), pulse wave velocity; total PA, total physical activity (LPA+MVPA).